Antibiotics

13 papers34 directions
Antibiotics is a research venue active since 2014 that focuses on the study of antimicrobial agents and their clinical applications. While its primary scope encompasses the characterization of antibiotic resistance and clinical outcomes, it serves as a specialized outlet for computational research at the intersection of pharmacology and data science. The venue features contributions from authors such as Chuhui Wang, Na He, Sixuan Zhao, and Suodi Zhai, covering topics ranging from the emergence of resistant strains to the optimization of dosing regimens for critically ill patients. In the field of machine learning and artificial intelligence, Antibiotics provides a platform for applying these technologies to drug discovery and molecular modeling. Research published at this venue includes the use of traditional machine learning and deep learning architectures for the design and discovery of antimicrobial peptides. Additionally, the venue hosts comparative assessments of docking programs used for the virtual screening of antibacterial agents, such as ribosomal oxazolidinone, demonstrating a focus on algorithmic approaches to identifying therapeutic candidates. Beyond molecular design, the venue publishes data-driven studies that utilize statistical and pharmacokinetic modeling to improve clinical practice. This includes population PK/PD analyses for dose optimization and the characterization of factors associated with microbiome disruption in patients receiving chemotherapy. By hosting research that combines clinical data with computational tools, Antibiotics facilitates the application of quantitative and algorithmic methods to complex challenges in infectious disease management and pharmacology.

Papers by Year

2025 1
2024 1
2023 2
2022 2
2021 5
2020 1
2014 1

Top Research Directions

Research directions most represented by papers from this venue.

Overcoming Pharmacokinetic Variability in Disease and Critical Illness 4
Countering the Molecular Mechanisms of Antibiotic Resistance 4
Overcoming Pathogen Spectrum Limitations in Antimicrobial Design 2
Quantifying Resistance via Minimum Inhibitory Concentrations 2
Deep Learning for Antimicrobial Peptide Discovery 2
Systemic Biases and Causal Limitations in Retrospective Studies 2
Saturation and Adaptation in Nonlinear Pharmacokinetics 1
Evolutionary Fitness Costs of Biological Resistance 1
Transferring Linguistic Priors to Biological Sequences 1
Scaling Chemical and Phenotypic Screens for Drug Discovery 1
Disrupting the Extracellular Matrix of Bacterial Biofilms 1
Modeling the Conformational Flexibility of RNA Structures 1
Synergistic In Silico and Experimental Drug Discovery 1
Hybrid Statistical and Neural Time Series Forecasting 1
De Novo Protein Design via Generative Sequence Modeling 1

Top Authors

AuthorPapers
Jielu Yan1
Jihad Mallat1
Pablo Arbelaez1

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Papers

TitleYear
Characterization of Antibiotic Administration Factors Associated with Microbiome Disruption and Subsequent Antibiotic-Resistant Infection and Colonization Events in Acute Myeloid Leukemia Patients Rec2025
Clinical Outcomes of Ceftazidime–Avibactam versus Ceftolozane–Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy2024
Comparative Assessment of Docking Programs for Docking and Virtual Screening of Ribosomal Oxazolidinone Antibacterial Agents2023
Phentolamine Significantly Enhances Macrolide Antibiotic Antibacterial Activity against MDR Gram-Negative Bacteria2023
Emergence of Colistin-Resistant Acinetobacter junii in China2022
Recent Progress in the Discovery and Design of Antimicrobial Peptides Using Traditional Machine Learning and Deep Learning2022
A Prediction Method for Animal-Derived Drug Resistance Trend Using a Grey-BP Neural Network Combination Model2021
Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis2021
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF2021
Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance2021
Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection2021
Design, Screening, and Testing of Non-Rational Peptide Libraries with Antimicrobial Activity: In Silico and Experimental Approaches2020
Anti-Biofilm and Immunomodulatory Activities of Peptides That Inhibit Biofilms Formed by Pathogens Isolated from Cystic Fibrosis Patients2014